Prostaglandin E2 inhibits proteinase-activated receptor 2-signal transduction through regulation of receptor internalization

Journal of Veterinary Medical Science

Volumn 75, Issue 3, 2013, Pages 255-261

  Komatsu, Hiroyuki ^a   Enjouji, Shuhei ^a   Ito, Akihiro ^a   Ohama, Takashi ^a   Sato, Koichi ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Prostaglandin E2 (PGE2); Proteinase activated receptor 2 (PAR2); Receptor internalization

Indexed keywords

2 FUROYL LIGRLO AMIDE; 2-FUROYL-LIGRLO-AMIDE; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOPEPTIDE; PROSTAGLANDIN E2; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; MICE; OLIGOPEPTIDES; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION;

EID: 84875800450     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.12-0365     Document Type: Article

References (36)

1. Abrahao, A. C., Castilho, R. M., Squarize, C. H., Molinolo, A. A., dos Santos-Pinto, D. and Gutkind, J. S. 2010. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Oncol. 46: 880-887. [Medline] [CrossRef]
2. Arora, P., Ricks, T. K. and Trejo, J. 2007. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J. Cell Sci. 120: 921-928. [Medline] [CrossRef]
3. Asokananthan, N., Graham, P. T., Fink, J., Knight, D. A., Bakker, A. J., McWilliam, A. S., Thompson, P. J. and Stewart, G. A. 2002. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J. Immunol. 168: 3577-3585. [Medline]
4. Blanc-Brude, O. P., Archer, F., Leoni, P., Derian, C., Bolsover, S., Laurent, G. J. and Chambers, R. C. 2005. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp. Cell Res. 304: 16-27. [Medline] [CrossRef]
5. Böhm, S. K., Khitin, L. M., Grady, E. F., Aponte, G., Payan, D. G. and Bunnett, N. W. 1996. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J. Biol. Chem. 271: 22003-22016. [Medline] [CrossRef]
6. Caraglia, M., Di, Gennaro, E., Barbarulo, D., Marra, M., Tagliaferri, P., Abbruzzese, A. and Budillon, A. 1999. Up-regulated EGF receptors undergo to rapid internalization and ubiquitindependent degradation in human cancer cells exposed to 8-ClcAMP. FEBS Lett. 447: 203-208. [Medline] [CrossRef]
7. Giuliano, F. and Warner, T. D. 2002. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J. Pharmacol. Exp. Ther. 303: 1001-1006. [Medline] [CrossRef]
8. Henry, P. J. 2006. The protease-activated receptor2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: a potential bronchoprotective unit in the respiratory tract? Eur. J. Pharmacol. 533: 156-170. [Medline] [CrossRef]
9. Howell, D. C., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J. and Chambers, R. C. 2005. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am. J. Pathol. 166: 1353-1365. [Medline] [CrossRef]
10. Kang, O. H., Jeong, H. J., Kim, D. K., Choi, S. C., Kim, T. H., Nah, Y. H., Kim, H. M. and Lee, Y. M. 2003. Trypsin induces tumour necrosis factor-alpha secretion from a human leukemic mast cell line. Cell Biochem. Funct. 21: 161-167. [Medline] [CrossRef]
11. Kawabata, A. 2011. Prostaglandin E2 and pain-an update. Biol. Pharm. Bull. 34: 1170-1173. [Medline] [CrossRef]
12. Kawabata, A., Matsunami, M. and Sekiguchi, F. 2008. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br. J. Pharmacol. 153(Suppl. 1): S230-S240. [Medline] [CrossRef]
13. Komatsu, H., Shimose, A., Shimizu, T., Mukai, Y., Kobayashi, J., Ohama, T. and Sato, K. 2012. Trypsin inhibits lipopolysaccharide signaling in macrophages via toll-like receptor 4 accessory molecules. Life Sci. 91: 143-150. [Medline] [CrossRef]
14. Manson, M. E., Corey, D. A., White, N. M. and Kelley, T. J. 2008. cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L809-L819. [Medline] [Cross-Ref]
15. McCaffrey, L. M. and Macara, I. G. 2009. The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes Dev. 23: 1450-1460. [Medline] [CrossRef]
16. Mosenden, R. and Taskén, K. 2011. Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell. Signal. 23: 1009-1016. [Medline] [CrossRef]
17. Mosher, A. A., Rainey, K. J., Giembycz, M. A., Wood, S. and Slater, D. M. 2012. Prostaglandin E2 Represses Interleukin 1 Beta-Induced Inflammatory Mediator Output From Pregnant Human Myometrial Cells Through the EP2 and EP4 Receptors. Biol. Reprod. 87: 1-10. [Medline] [CrossRef]
18. Nagataki, M., Moriyuki, K., Sekiguchi, F. and Kawabata, A. 2008. Evidence that PAR2-triggered prostaglandin E2 (PGE2) formation involves the ERK-cytosolic phospholipase A2-COX-1-microsomal PGE synthase-1 cascade in human lung epithelial cells. Cell Biochem. Funct. 26: 279-282. [Medline] [CrossRef]
19. Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L. A., Shariat, N., Vodjgani, M., Warren, K. G., Andrade-Gordon, P., Hollenberg, M. D. and Power, C. 2006. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203: 425-435. [Medline] [CrossRef]
20. Peters, T. and Henry, P. J. 2009. Protease-activated receptors and prostaglandins in inflammatory lung disease. Br. J. Pharmacol. 158: 1017-1033. [Medline] [CrossRef]
21. Ricks, T. K. and Trejo, J. 2009. Phosphorylation of proteaseactivated receptor-2 differentially regulates desensitization and internalization. J. Biol. Chem. 284: 34444-34457. [Medline] [CrossRef]
22. Rothmeier, A. S. and Ruf, W. 2012. Protease-activated receptor 2 signaling in inflammation. Semin. Immunopathol. 34: 133-149. [Medline] [CrossRef]
23. Rundhaug, J. E., Simper, M. S., Surh, I. and Fischer, S. M. 2011. The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev. 30: 465-480. [Medline] [CrossRef]
24. Sakata, D., Yao, C. and Narumiya, S. 2010. Prostaglandin E2, an immunoactivator. J. Pharmacol. Sci. 112: 1-5. [Medline] [CrossRef]
25. Sands, W. A. and Palmer, T. M. 2008. Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal. 20: 460-466. [Medline] [CrossRef]
26. Schmidlin, F., Amadesi, S., Dabbagh, K., Lewis, D. E., Knott, P., Bunnett, N. W., Gater, P. R., Geppetti, P., Bertrand, C. and Stevens, M. E. 2002. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 169: 5315-5321. [Medline]
27. Sekiguchi, F., Ohi, A., Maeda, Y., Takaoka, K., Sekimoto, T., Nishikawa, H. and Kawabata, A. 2011. Delayed production of arachidonic acid contributes to the delay of proteinase-activated receptor-1 (PAR1)-triggered prostaglandin E2 release in rat gastric epithelial RGM1 cells. J. Cell. Biochem. 112: 909-915. [Medline] [CrossRef]
28. Shi, J., Luo, Q., Chen, F., Chen, D., Xu, G. and Li, H. 2010. Induction of IL-6 and IL-8 by house dust mite allergen Der p1 in cultured human nasal epithelial cells is associated with PAR/ PI3K/NFkappaB signaling. ORL J. Otorhinolaryngol. Relat. Spec. 72: 256-265. [Medline] [CrossRef]
29. Sokolova, E., Hartig, R. and Reiser, G. 2008. Downregulation of protease-activated receptor-1 in human lung fibroblasts is specifically mediated by the prostaglandin E receptor EP2 through cAMP elevation and protein kinase A. FEBS J. 275: 3669-3679. [Medline] [CrossRef]
30. Sugimoto, Y. and Narumiya, S. 2007. Prostaglandin E receptors. J. Biol. Chem. 282: 11613-11617. [Medline] [CrossRef]
31. Tanaka, Y., Sekiguchi, F., Hong, H. and Kawabata, A. 2008. PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochem. Biophys. Res. Commun. 377: 622-626. [Medline] [CrossRef]
32. Ueta, M., Matsuoka, T., Sotozono, C. and Kinoshita, S. 2012. Prostaglandin E2 Suppresses Poly I: C-Stimulated Cytokine Production Via EP2 and EP3 in Immortalized Human Corneal Epithelial Cells. Cornea [CrossRef]. [Medline]
33. Valdez, P. A., Vithayathil, P. J., Janelsins, B. M., Shaffer, A. L., Williamson, P. R. and Datta, S. K. 2012. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36: 668-679. [Medline] [CrossRef]
34. Weinberg, E., Zeldich, E., Weinreb, M. M., Moses, O., Nemcovsky, C. and Weinreb, M. 2009. Prostaglandin E2 inhibits the proliferation of human gingival fibroblasts via the EP2 receptor and Epac. J. Cell. Biochem. 108: 207-215. [Medline] [Cross-Ref]
35. Williams, T. J. and Peck, M. J. 1977. Role of prostaglandinmediated vasodilatation in inflammation. Nature 270: 530-532. [Medline] [CrossRef]
36. Yen, J. H., Kocieda, V. P., Jing, H. and Ganea, D. 2011. Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation. J. Biol. Chem. 286: 38913-38923. [Medline] [CrossRef]